CLINICAL_TRIALS
trial_result
· 2022-07-27
Clinical Trial Update: Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma [Phase 3]
Summary
Phase 3 clinical trial update evaluating efficacy and safety of Flamboyant 200/12 association in adults with severe asthma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMS | Conditions: Asthma | Phase 3 | Status: UNKNOWN